Search

everythinglearnresearchcommunity

for

Search:↓

Chitosan-decorated nanoparticles can improve skin delivery and reduce side effects of finasteride.

The growth factor cocktail significantly increased hair growth in patients with androgenetic alopecia.

Better hair loss models needed for research.

Solanum nigrum extract may help regrow hair.

Hormonal antiandrogen therapy for acne is underused and can reduce the need for antibiotics.

Risk analysis is important for safely adjusting pharmaceutical formulas while maintaining their quality and effectiveness.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

2-deoxy-D-ribose gel may help regrow hair in cases of hair loss.

Low-dose oral Minoxidil is an effective treatment for hair loss with minimal serious side effects.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

Adding a second method to PROTACs could improve cancer treatment.

Health warnings and public health actions led to a significant drop in flutamide prescriptions for women, but off-label use still continues.

NTF gel improves finasteride delivery for hair loss treatment, reducing side effects.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Finasteride helps hair growth but may cause sexual side effects and depression.

Accurate quantitative bioanalysis using LC-MS/MS is challenging due to matrix effects, but using internal standards and new methods like in-sample calibration could improve results.

The new face mask with Eflornithine can potentially reduce facial hair growth and moisturize skin.

Early diagnosis and personalized treatment are crucial for managing hair loss in children.

Fullerenes show potential in skin care but need more safety research.

New regenerative medicine-based therapies for hair loss look promising but need more clinical validation.

Higher cell number PRP improves hair density and diameter more than lower cell number PRP.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Finasteride may increase suicide risk; more research needed.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

Finasteride effectively prevents biofilm formation and treats preformed biofilms, but requires high doses.

Exposure to the hair loss drug finasteride during pregnancy can cause genital anomalies in male babies, but not in female babies. It's best to avoid this drug in women who could potentially become pregnant.